A case of ecthyma during therapy with an epidermal growth factor receptor inhibitor

被引:0
|
作者
Takashi Mizuno
Tomohiko Tanegashima
Aki Suzuki
Sayaka Kuze
Takashi Koyama
机构
[1] Odawara Municipal Hospital,Department of Dermatology
[2] Odawara Municipal Hospital,Department of Surgery
来源
关键词
Cetuximab; Panitumumab; Epidermal Growth Factor Receptor Inhibitor; Impetigo; Chromatin Assembly;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:511 / 512
页数:1
相关论文
共 50 条
  • [1] A case of ecthyma during therapy with an epidermal growth factor receptor inhibitor
    Mizuno, Takashi
    Tanegashima, Tomohiko
    Suzuki, Aki
    Kuze, Sayaka
    Koyama, Takashi
    EUROPEAN JOURNAL OF DERMATOLOGY, 2014, 24 (04) : 511 - 512
  • [2] Cutaneous adverse reactions during epidermal growth factor receptor inhibitor therapy
    Ragin, Dominika
    Basalygo, Magdalena
    Nowacka, Katarzyna
    Zegarska, Barbara
    PRZEGLAD DERMATOLOGICZNY, 2018, 105 (03): : 421 - 433
  • [3] Cutaneous adverse effects during therapy with an epidermal growth factor receptor (EGFR) inhibitor
    Santoro, Francesca
    Cozzani, Emanuele
    Parodi, Aurora
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2006, 17 (03) : 160 - 161
  • [4] Perifollicular Xanthomas Associated with Epidermal Growth Factor Receptor Inhibitor Therapy
    Eames, Tatiana
    Kroth, Julia
    Flaig, Michael J.
    Ruzicka, Thomas
    Wollenberg, Andreas
    ACTA DERMATO-VENEREOLOGICA, 2010, 90 (02) : 202 - 203
  • [5] Nail toxicity associated with epidermal growth factor receptor inhibitor therapy
    Fox, Lindy P.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (03) : 460 - 465
  • [6] Demodex inflammatory eruption due to epidermal growth factor receptor inhibitor therapy
    Chon, S. Y.
    Hassler, A. A.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 174 (03) : 686 - 687
  • [7] Trichomegaly of the eyelashes during therapy with epidermal growth factor receptor inhibitors: Observational case series
    Maka, V. V.
    ANNALS OF ONCOLOGY, 2015, 26 : 138 - 138
  • [8] Severe acneiform skin reaction during therapy with erlotinib (Tarceva®), an epidermal growth factor receptor (EGFR) inhibitor
    Eames, Tatjana
    Landthaler, Michael
    Karrer, Sigrid
    EUROPEAN JOURNAL OF DERMATOLOGY, 2007, 17 (06) : 552 - 553
  • [9] A case of epidermal growth factor receptor tyrosine kinase inhibitor effectiveness in epidermal growth factor receptor mutation-positive squamous cell carcinoma
    Matsumura, Sosuke
    Ano, Satoshi
    Kikuchi, Norihiro
    Masuda, Michiko
    Osawa, Hajime
    Kondo, Yuzuru
    Ishii, Yukio
    Hizawa, Nobuyuki
    SAGE OPEN MEDICAL CASE REPORTS, 2023, 11
  • [10] BB, a novel epidermal growth factor receptor inhibitor
    Wheeler, Deric L.
    Dunn, Emily F.
    CANCER BIOLOGY & THERAPY, 2009, 8 (17) : 1655 - 1657